Author:
Toth Karoly,Tollefson Ann E.,Spencer Jacqueline F.,Ying Baoling,Wold William S.M.
Funder
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services
Reference40 articles.
1. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients;Asberg;Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg.,2007
2. Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival;Bruno;Biol. Blood Marrow Transpl.,2003
3. The use of brincidofovir for the treatment of mixed dsDNA viral infection;Camargo;J. Clin. Virol.,2016
4. Achievements in public Health, 1900-1999: control of infectious diseases;CDC;Morb. Mortal. Wkly. Rep.,1999
5. Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers;(CDER),2005
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献